<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03323138</url>
  </required_header>
  <id_info>
    <org_study_id>NL-HZ</org_study_id>
    <nct_id>NCT03323138</nct_id>
  </id_info>
  <brief_title>Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma</brief_title>
  <acronym>PACG</acronym>
  <official_title>Prospective Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary angle-closure glaucoma (PACG) is common, phacotrabeculectomy is associated with a
      significant risk of complications.The Ex-PRESS shunt was introduced as a modification to
      trabeculectomy, with the theoretical advantages of reduced complications.Our purpose is to
      perform a prospective study to evaluate the clinical outcomes and safety of the Ex-PRESS
      shunt with cataract surgery for PACG patients coexisting cataract.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Ex-PRESS is a miniature stainless steel glaucoma device, developed as an alternative to
      trabeculectomy mainly for patients with primary open-angle glaucoma.It has been proved to be
      as effective as trabeculectomy in a series of researches. However the early postoperative
      complication of Ex-PRESS implantation is less frequent compared with trabeculectomy. Ex-PRESS
      was designed initially for open angle glaucoma, gradually some scholars used it in refractory
      postpenetrating keratoplasty glaucoma and in vitrectomized glaucoma,which showed that
      Ex-PRESS shunt implantation was an effective procedure too. We analyzed the clinical efficacy
      and safety of combined phacoemulsification and Ex-PRESS implantation for PACG patients with
      cataract. Data was recorded before surgery and postoperatively at 1 week and 1, 3, 6,
      12,18,24,30,36 monthsï¼Œwhich included intraocular pressure (IOP), best corrected visual acuity
      (BCVA), number of medications, complications, corneal endothelial cell density and anterior
      segment optical coherence tomography(AS-OCT). Efficacy was assessed by IOP values and success
      rates. Complete success was determined by IOP between 5 and 21mmHg without medications.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2012</start_date>
  <completion_date type="Anticipated">December 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective, interventional and monocentric study based in a university hospital setting</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular pressure (IOP)</measure>
    <time_frame>36 months</time_frame>
    <description>In millimeters of mercury (mmHg), measured with the Goldmann applanation tonometer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraocular pressure (IOP)</measure>
    <time_frame>2 weeks, 1 month, 3 months, 6 months, 12 months,18 months, 24 months, 30 months,36 months.</time_frame>
    <description>In millimeters of mercury (mmHg), measured with the Goldmann applanation tonometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of intraocular pressure lowering medications</measure>
    <time_frame>2 weeks, 1 month, 3 months, 6 months, 12 months,18 months, 24 months, 30 months,36 months.</time_frame>
    <description>Number of drops and oral medications used by the patient compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best corrected visual acuity (BCVA)</measure>
    <time_frame>2 weeks, 1 month, 3 months, 6 months, 12 months,18 months, 24 months, 30 months,36 months.</time_frame>
    <description>Number of lines reduction or improvement from baseline on Snellen acuity chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal endothelial cell density</measure>
    <time_frame>3 months</time_frame>
    <description>Use non-contact specular microscope to count the endothelial cell density (cells/mm2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anterior chamber distance(ACD)</measure>
    <time_frame>3 months</time_frame>
    <description>The distance from inner corneal surface to lens measured by AS-OCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angle opening distance(AOD500)</measure>
    <time_frame>3 months</time_frame>
    <description>Angle opening distance 500um from the scleral spur measured by AS-OCT</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Glaucoma, Angle-Closure</condition>
  <arm_group>
    <arm_group_label>Ex-PRESS and phacoemulsification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A treatment session of PACG coexisting cataract treated with phacoemulsification combined with P50 Ex-PRESS miniature glaucoma device (Alcon Laboratories, Fort Worth, Texas, USA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ex-PRESS and phacoemulsification</intervention_name>
    <arm_group_label>Ex-PRESS and phacoemulsification</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The presence of PACG, angle peripheral anterior synechia (PAS) more than 180 degrees.

          -  An indication for glaucoma filtering surgery based on uncontrolled IOP or progressive
             vision field defect despite antiglaucoma medications.

          -  Mean vision field defect greater than 15dB.

          -  The presence of a clinically significant decrease of visual acuity as a result of
             cataract, usually BCVA less than 0.6.

        Exclusion Criteria:

          -  Patients unable to give informed consent.

          -  Ocular infection or inflammation in the study eye in the 3 months prior to enrollment.

          -  Intraocular surgery in the study eye in the 3 months prior to enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ai wu Fang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li Nie, MD</last_name>
    <phone>+86-0571-86795965</phone>
    <email>hehemao2003@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ai wu Fang, MD</last_name>
    <phone>+86-0571-88068888</phone>
    <email>953736995@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ophthalmology and Optometry Hospital , Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325027</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Nie, MD</last_name>
      <phone>+86-0571-86795959</phone>
      <email>nl@mail.eye.ac.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Lai JS, Tham CC, Lam DS. Incisional surgery for angle closure glaucoma. Semin Ophthalmol. 2002 Jun;17(2):92-9. Review.</citation>
    <PMID>15513462</PMID>
  </results_reference>
  <results_reference>
    <citation>Tham CC, Lai JS, Poon AS, Lai TY, Lam DS. Results of trabeculectomy with adjunctive intraoperative mitomycin C in Chinese patients with glaucoma. Ophthalmic Surg Lasers Imaging. 2006 Jan-Feb;37(1):33-41.</citation>
    <PMID>16468549</PMID>
  </results_reference>
  <results_reference>
    <citation>Tham CC, Kwong YY, Leung DY, Lam SW, Li FC, Chiu TY, Chan JC, Lam DS, Lai JS. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology. 2009 Apr;116(4):725-31, 731.e1-3. doi: 10.1016/j.ophtha.2008.12.054. Epub 2009 Feb 25.</citation>
    <PMID>19243831</PMID>
  </results_reference>
  <results_reference>
    <citation>Beltran-Agullo L, Trope GE, Jin Y, Wagschal LD, Jinapriya D, Buys YM. Comparison of visual recovery following ex-PRESS versus trabeculectomy: results of a prospective randomized controlled trial. J Glaucoma. 2015 Mar;24(3):181-6. doi: 10.1097/IJG.0b013e31829e1b68.</citation>
    <PMID>23807352</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzalez-Rodriguez JM, Trope GE, Drori-Wagschal L, Jinapriya D, Buys YM. Comparison of trabeculectomy versus Ex-PRESS: 3-year follow-up. Br J Ophthalmol. 2016 Sep;100(9):1269-73. doi: 10.1136/bjophthalmol-2015-307161. Epub 2015 Dec 16.</citation>
    <PMID>26674779</PMID>
  </results_reference>
  <results_reference>
    <citation>Netland PA, Sarkisian SR Jr, Moster MR, Ahmed II, Condon G, Salim S, Sherwood MB, Siegfried CJ. Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study). Am J Ophthalmol. 2014 Feb;157(2):433-440.e3. doi: 10.1016/j.ajo.2013.09.014. Epub 2013 Nov 7.</citation>
    <PMID>24210765</PMID>
  </results_reference>
  <results_reference>
    <citation>Zhang M, Li B, Sun Y. EX-PRESS and ahmed glaucoma valve in treatment of refractory glaucoma. Acta Ophthalmol. 2016 Aug;94(5):e382-3. doi: 10.1111/aos.12898. Epub 2015 Dec 8.</citation>
    <PMID>26643962</PMID>
  </results_reference>
  <results_reference>
    <citation>Liu B, Guo DD, Du XJ, Cong CY, Ma XH. Evaluation of Ex-PRESS implantation combined with phacoemulsification in primary angle-closure glaucoma. Medicine (Baltimore). 2016 Sep;95(36):e4613. doi: 10.1097/MD.0000000000004613.</citation>
    <PMID>27603352</PMID>
  </results_reference>
  <results_reference>
    <citation>Wagschal LD, Trope GE, Jinapriya D, Jin YP, Buys YM. Prospective Randomized Study Comparing Ex-PRESS to Trabeculectomy: 1-Year Results. J Glaucoma. 2015 Oct-Nov;24(8):624-9. doi: 10.1097/IJG.0000000000000029.</citation>
    <PMID>24247999</PMID>
  </results_reference>
  <results_reference>
    <citation>Marzette L, Herndon LW. A comparison of the Ex-PRESSâ„¢ mini glaucoma shunt with standard trabeculectomy in the surgical treatment of glaucoma. Ophthalmic Surg Lasers Imaging. 2011 Nov-Dec;42(6):453-9. doi: 10.3928/15428877-20111017-03.</citation>
    <PMID>22074705</PMID>
  </results_reference>
  <results_reference>
    <citation>Vetrugno M, Ferreri P, Sborgia C. Ex-PRESS miniature glaucoma device in vitrectomized eyes. Eur J Ophthalmol. 2010 Sep-Oct;20(5):945-7.</citation>
    <PMID>20306441</PMID>
  </results_reference>
  <results_reference>
    <citation>Kanner EM, Netland PA, Sarkisian SR Jr, Du H. Ex-PRESS miniature glaucoma device implanted under a scleral flap alone or combined with phacoemulsification cataract surgery. J Glaucoma. 2009 Aug;18(6):488-91. doi: 10.1097/IJG.0b013e31818fb44e.</citation>
    <PMID>19223790</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>October 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2017</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>yin ying zhao</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Ex-PRESS</keyword>
  <keyword>glaucoma</keyword>
  <keyword>filtration surgery</keyword>
  <keyword>phacoemulsification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Angle-Closure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

